China Industrial Asset Management Leads $40M Series C1 Round In Chinese Cancer Immunotherapy Company

Violet Tang
November 26, 2018 — 11:16 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: Artificial Intelligence automobile automotive bank China China Industrial Asset Management Limited chinese electric vehicle guangdong healthcare investment Legend Capital Manufacturer medicine NIO pharmaceutical Private Equity Shanghai Shanghai Cell Therapy Group Co. shenzhen technology venture capital Website yitu technology

Related News:

China Establishes Nationwide Regulations for Commercial Use of Autonomous Vehicles

December 6, 2023 — 01:50

China’s Energy Sector Invests in Hydrogen Projects to Achieve National Dual Carbon Goals

December 4, 2023 — 23:32

Chinese Charitable Foundations Expand Into Alternative Investments To Enhance Returns

November 30, 2023 — 23:50

ByteDance’s ChatGPT-Powered AI Chatbot Cici Tops Charts in Emerging Markets

November 29, 2023 — 23:23

ByteDance to Dissolve Gaming Unit After Failing to Find a Buyer

November 28, 2023 — 03:29

Huawei Spins Off Intelligent Automotive Solutions Unit To Secure Fresh Funding

November 27, 2023 — 23:45

ByteDance Establishes New AI Division To Accelerate Consumer Product Deployment

November 27, 2023 — 23:10

Bahrain’s Investcorp Targets RMB2-4 Billion Buyout Fund in China

November 25, 2023 — 00:58

ByteDance to Sell Moonton Gaming Studio in Strategic Retreat From Gaming

November 23, 2023 — 00:00